4//SEC Filing
DAVIS JOHN C. JR 4
Accession 0001562180-19-006220
CIK 0001690585other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 5:52 PM ET
Size
12.2 KB
Accession
0001562180-19-006220
Insider Transaction Report
Form 4
DAVIS JOHN C. JR
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2019-12-20$9.49/sh+114$1,082→ 8,418 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-20−805→ 236,239 totalExercise: $9.49Exp: 2028-04-25→ Common Stock (805 underlying) - Exercise/Conversion
Common Stock
2019-12-20$9.49/sh+805$7,639→ 9,223 total - Sale
Common Stock
2019-12-20$15.00/sh−919$13,785→ 8,304 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-12-20−114→ 236,125 totalExercise: $9.49Exp: 2028-04-25→ Common Stock (114 underlying)
Footnotes (2)
- [F1]This trade is pursuant to an active 10b5-1 plan.
- [F2]25% vested on February 16, 2019 with the remaining 75% vesting in 12 equal quarterly installments thereafter.
Documents
Issuer
Magenta Therapeutics, Inc.
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001741287
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 5:52 PM ET
- Size
- 12.2 KB